4.6 Article

Functional Differences between Proteasome Subtypes

Journal

CELLS
Volume 11, Issue 3, Pages -

Publisher

MDPI
DOI: 10.3390/cells11030421

Keywords

proteasome subtypes; protein degradation; ATP- and ubiquitin-dependent degradation; ATP- and ubiquitin-independent degradation; MHC class I peptides; autoimmune diseases

Categories

Ask authors/readers for more resources

This review focuses on the different subtypes of proteasomes and their roles in maintaining protein homeostasis, protein degradation, and immune response. The mechanisms of ATP- and ubiquitin-dependent protein degradation are described, along with the ATP- and ubiquitin-independent degradation process. The review also discusses the generation of peptides presented by MHC class I molecules and the potential therapeutic application of proteasome modulation in autoimmune diseases.
Four proteasome subtypes are commonly present in mammalian tissues: standard proteasomes, which contain the standard catalytic subunits beta 1, beta 2 and beta 5; immunoproteasomes containing the immuno-subunits beta 1i, beta 2i and beta 5i; and two intermediate proteasomes, containing a mix of standard and immuno-subunits. Recent studies revealed the expression of two tissue-specific proteasome subtypes in cortical thymic epithelial cells and in testes: thymoproteasomes and spermatoproteasomes. In this review, we describe the mechanisms that enable the ATP- and ubiquitin-dependent as well as the ATP- and ubiquitin-independent degradation of proteins by the proteasome. We focus on understanding the role of the different proteasome subtypes in maintaining protein homeostasis in normal physiological conditions through the ATP- and ubiquitin-dependent degradation of proteins. Additionally, we discuss the role of each proteasome subtype in the ATP- and ubiquitin-independent degradation of disordered proteins. We also discuss the role of the proteasome in the generation of peptides presented by MHC class I molecules and the implication of having different proteasome subtypes for the peptide repertoire presented at the cell surface. Finally, we discuss the role of the immunoproteasome in immune cells and its modulation as a potential therapy for autoimmune diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available